Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | 17-AAG | FIMM | pan-cancer | AAC | 0.076 | 0.7 |
mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.016 | 0.7 |
mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.7 |
mRNA | Platin | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.021 | 0.7 |
mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.022 | 0.7 |
mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Axitinib | FIMM | pan-cancer | AAC | 0.066 | 0.7 |